ARS Share Price

ARS Share Price

NASDAQ: SPRY | Micro Cap | Healthcare
$2.96
-$0.42 (-12.3%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

ARS Stock Performance

Open
$3.40
Prev. Close
$3.38
Circuit Range
N/A
Day Range
$2.86 - $3.46
Year Range
$2.46 - $13.14
Volume
1,79,659
Average Traded
$3.11

ARS Share Price Today

As of 22 November 2026, ARS Pharmaceuticals, Inc.'s share price is $2.96. The stock opened at $3.40, compared to its previous close of $3.38. During today's trading session, ARS Pharmaceuticals, Inc.'s share price traded between $2.86 and $3.46, with an average price of $3.16. Over the past 52 weeks, the stock has recorded a high of $13.14 and a low of $2.46. In terms of performance, ARS Pharmaceuticals, Inc.'s share price has declined by 67.36% over the last six months and is down 68.94% on a year-on-year basis.

ARS Share Price Chart

Line chart of the ARS price trend over the selected period. The price fell overall, ranging from 2.86 to 3.46, ending at 2.96.
$2.86$3.46
L
Show Current Price
H

ARS Stock Fundamentals & Key Indicators

Market Cap
$291.76M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.99
Revenue (TTM)
$84.28B
Return On Equity (TTM)
1669.94%
Profit Margin
-203.25%
Debt to Equity
-16.48
Quarterly Earnings Growth YoY
13.41%

ARS Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$28.09$22.68$33.66$37.71
Net Profit-$41.10-$60.62-$62.34-$35.59
Net Profit Margin-146.32%-267.28%-185.20%-94.38%
Income ChangeN/A-47.49%-2.84%42.91%

ARS Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.32$0.03$89.15$84.28
Net Profit-$34.68-$54.37$8.00-$171.30
Net Profit Margin-2627.27%-181233.33%8.97%-203.25%
Income ChangeN/A-56.78%114.71%-2241.25%

ARS Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets42.7616.861.463.74
Current Assets284.9334.3231.73277.7
Total Assets327.65351.15233.19281.44
Non Current Liabilities174.2570.920.043.11
Current Liabilities39.1523.442.395.44
Total Liabilities213.3994.362.438.55
Shareholders' Equity114.26256.8230.76272.89

ARS Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-170.8713.55-59.27-40.08
Investing56.77-106.1-87.18-0.2
Financing104.672.46.9190.73

About ARS

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

ARS Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.48
$2.96
-12.44%
Oct 2026
$4.36
$3.38
-22.06%
Sep 2026
$5.99
$4.33
-28.07%
Aug 2026
$5.02
$6.02
+17.81%
Jul 2026
$8.01
$5.11
-36.20%
Jun 2026
$9.25
$8.01
-11.69%
May 2026
$8.28
$9.07
+9.94%
Apr 2026
$8.18
$8.25
+2.75%
Mar 2026
$8.99
$8.03
-13.67%
Feb 2026
$10.00
$9.30
-7.09%
Jan 2026
$11.52
$10.01
-14.15%
Dec 2025
$9.37
$11.66
+22.35%

ARS Share Price FAQs